In addition to its applicability in healthy and psychotic, otherwise healthy, populations, it was demonstrated that the haloperidol PBPK model can be applied to predict PK parameters in TB patients and the effect of interaction with anti-TB rifampicin, which is a potent CYP3A4 inducer. Here, CYP3A4 is linked to tuberculosis.